 SEATTLE, Dec. 6, 2020 PRNewswire -- CTI BioPharma Corp. Nasdaq: CTIC today announced an oral presentation supporting the Companys pacritinib development program in the prevention of acute graft versus host disease GVHD at the 62nd American Society of Hematology ASH Annual Meeting... 